2016-03-13T00:00:00.000-05:00
cystic fibrosis,-0.678021
therapeutics,0.438182
analysts,0.504652
reports earnings,-0.30474
S&P500,-0.455075
lead product candidate,0.209161
treatment,-0.630892
latest news,0.504652
email newsletter,0.580274
clinical-stage biopharmaceutical company,0.338105
scleroderma,-0.678021
Inc.,0.338105
commercialization,0.438182
Ratings Via Email,0.398382
concise daily summary,0.504652
negative earnings,-0.772623
Receive News,0.398382
email address,0.504652
inflammatory disorders,-0.630892
oral anti-inflammatory drug,-0.630892
life-threating inflammatory-fibrotic diseases,-0.498538
